Hodgkin Lymphoma: The Latest in Treatment and Research

Medically reviewed by Philippe Armand, MD, PhD, and Margaret A. Shipp, MD Hodgkin lymphoma (HL) is a cancer that begins in white blood cells called lymphocytes, which play a significant role in the body’s immune system against disease. There have been major advances in the treatment of in the past several years. A two-in-one drug … Continued

Hodgkin Lymphoma Patient Aims to Lessen Cancer Stigma

Chloe Svolos is a social butterfly. When she isn’t working in the fundraising office for Dana-Farber’s Jimmy Fund, the 26-year-old is spending time with family, going out with friends, hanging out with her boyfriend, Luke, or traveling. She also recently completed treatment for lymphoma — so she’s still adjusting to her “new normal.” But in … Continued

From Patient to Employee: A Return to Dana-Farber

No athlete welcomes an injury, but a simple scratch may have saved Rich Oakley’s life. Oakley was diagnosed with cancer in 2003, as a high school senior, after a scratch from a sports injury led to a swollen neck. When the swelling didn’t subside, Oakley’s mother brought him to the doctor for tests, which revealed … Continued

What Are the Different Stages of Lymphoma?

Medically reviewed by Ann S. LaCasce, MD, MMSc After a patient is diagnosed with lymphoma, doctors determine the stage of the disease – or how widespread the cancer is – and then come up with a treatment plan. As with most cancers, there are generally four different stages of lymphoma: I, II, III, and IV. … Continued

Cancer Treatment: A Look at How It Has Evolved in 70 Years

In 1947, when Dana-Farber Cancer Institute founder Sidney Farber, MD, set out to find a drug treatment for childhood leukemia, cancer treatment took two forms – surgery to cut out cancerous masses, and radiation therapy to burn them out. Cancers that couldn’t be removed or irradiated – either because of their position in the body, because … Continued

Hodgkin Lymphoma Survivorship and Follow-Up Care

Adult Hodgkin lymphoma has one of the highest cure rates among all cancers. Still, the standard lymphoma therapies – including chemotherapy, radiation, surgery, and steroid therapy – may result in long-term side-effects beginning during treatment, and/or late-term effects arising years or decades after treatment. This is why check-ups and screenings are so important following treatment. … Continued

5 Tips for Being Confident as a Cancer Patient

Business consultant and former scientist Jordan Kraft didn’t always have the confident presence she has today. The 29-year-old was once a shy child who hated being in front of people. With encouragement from her parents, young Jordan started performing in plays – first as the Cowardly Lion in The Wizard of Oz – and slowly … Continued

New Immunotherapy Therapy Approved for Lymphoma Patients

The Food and Drug Administration (FDA) approved a new kind of immunotherapy drug for adults and children with classical Hodgkin lymphoma who have relapsed after three or more prior lines of therapy. The approved drug, pembrolizumab (Keytruda), is part of a class of immunotherapy drugs called checkpoint inhibitors that block the PD-1 protein, which is … Continued

What’s the Difference Between Hodgkin Lymphoma and Non-Hodgkin Lymphoma?

Although the diseases may sound similar, there is a lot of difference between Hodgkin and non-Hodgkin lymphoma. Both Hodgkin and non-Hodgkin lymphoma are malignancies of a family of white blood cells known as lymphocytes, which help the body fight off infections and other diseases. Hodgkin lymphoma is marked by the presence of Reed-Sternberg cells, which … Continued

How a Cure for Hodgkin Lymphoma Changed the Course of Cancer Treatment

To mark its 50th anniversary, the American Society of Clinical Oncology (ASCO) invited physicians, patients, and the public to name the most important advances in clinical cancer research in the past half century. From more than 2,000 responses, the top choice was a cure for advanced Hodgkin lymphoma developed by scientists at the National Cancer … Continued

Hodgkin Lymphoma: Five Things You Need to Know

Approximately 173,000 people in the United States are living with Hodgkin lymphoma, or are in remission. Less common than non-Hodgkin lymphoma, Hodgkin lymphoma (sometimes referred to as Hodgkin’s lymphoma) is a malignancy of B lymphocytes, an important cell in the immune system. This malignant B cell is known as the Reed-Sternberg cell. Arnold Freedman, MD, … Continued